LGC’s SARS-CoV-2 ultra-high throughput End-Point PCR test EUA authorised by FDA
News - Nexar™-based workflow enables simple, scalable, and cost-effective COVID-19 testing
27 April 2022
LGC’s new state-of-the-art site in Oxford will deliver critical diagnostics solutions and research
News - Facility will serve as home of The Native Antigen Company and an advanced workflow applications laboratory for LGC Biosearch Technologies
16 September 2022
LGC acquires PolyDesign
News - LGC acquires PolyDesign, a provider of innovative oligo solid support products for life sciences customers.
14 November 2023
LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning
News - LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning. This groundbreaking product rapidly delivers high-purity DNA in high-yields, typically achieving results in 5 minutes
15 January 2024